Burna AI is one engine from first-in-human trials through postmarket surveillance: the MedDRA LLT coding, per-drug WHO-UMC and Kramer attribution and source evidence it applies to a trial adverse event carry over to a postmarket case report. What ships today is report generation from the graded, signed record: FDA MedWatch, IRB and serious adverse event reports, downloaded as documents. Postmarket case processing is the next lane for the same engine, so a signal after approval can be read against the trial record behind the label, with the same criteria and the same evidence. To scope postmarket work for a product, book a 15-minute conversation at burna.ai/request-demo.
Interactive demo
Try Burna right now, no sign up required.